Fábio Fiúza Rosa
Fábio Fiúza Rosa is graduated in Biology and holds a MSc in Biochemistry, both by University of Coimbra. He is currently a PhD student at Center for Neurosciences and Cell Biology (CNC) from University of Coimbra (PDBEB) and at the Faculty of Medicine of Lund University. He holds 3 patents and is Co-founder of two start-ups: BRT Blood Reprogramming Technologies, Lda (Coimbra, Portugal) and Asgard Therapeutics AB (Lund, Sweden). Fábio Fiúza Rosa participated in multiple accelerator programs, being awarded with Arrisca C (University of Coimbra, 2016), Entrepreneurship competition Montepio Acredita Portugal (Health Prize 2017). Recently, he was awarded with the Jury’s Best Pitch Award promoted by EIT Health (Oxford University, UK. August 2019).